Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess Antimicrobial agents and chemotherapy 61 (2), e02089-16, 2017 | 108 | 2017 |
Anti-thymocyte globulin in haematology: Recent developments S Siddiqui, J Cox, R Herzig, S Palaniyandi, GC Hildebrandt, R Munker The Indian Journal of Medical Research 150 (3), 221, 2019 | 12 | 2019 |
Hemophagocytic Lymphohistiocytosis secondary to CAR‐T cells: Update from the FDA and Vizient databases S Priyadarshini, A Harris, D Treisman, JN Cupac, N Li, D Yan, R Munker American Journal of Hematology, 0 | 8 | |
Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia E Hickey, B Clemons, S Griffin, J Cox, S Sutphin, R Ramlal, L Benitez Leukemia & Lymphoma 60 (14), 3557-3560, 2019 | 7 | 2019 |
Myasthenia gravis and Guillain-Barré syndrome adverse events with immune checkpoint inhibitors. CR Garcia, JN Cox, JL Villano Journal of Clinical Oncology 36 (5_suppl), 37-37, 2018 | 7 | 2018 |
Sensitizing the interdisciplinary team to desensitizations: An alemtuzumab case report MG McKenzie, BD Bissell, MA Disselkamp, GC Hildebrandt, JN Cox Journal of Oncology Pharmacy Practice 26 (3), 742-746, 2020 | 2 | 2020 |
Drugs That Act on the Immune System: Cytokines and Monoclonal Antibodies K Ratermann, J Cox, L Benitez, F Davis Side Effects of Drugs Annual 40, 477-487, 2018 | 2 | 2018 |
Acute Kidney Injury During Therapy With Vancomycin in Combination With β-Lactams J Cox, WC Rutter, C Martin, DR Burgess, D Zephyr, DS Burgess Open Forum Infectious Diseases 2 (suppl_1), 126, 2015 | | 2015 |